Journal Articles - Health - 2021

Permanent URI for this collection

http://repository.vlu.edu.vn:443/handle/123456789/158

Browse

Browsing Journal Articles - Health - 2021 by Subject "Preclinical"
  • Publication
    Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy
    ( 2021)
    The Hong Phong Nguyen
    ;
    V. Bharath Kumar
    ;
    Vinoth Kumar Ponnusamy
    ;
    Thi Thu Thao Mai
    ;
    Phuong Tran Nhat
    ;
    Kathirvel Brindhadevi
    ;
    Arivalagan Pugazhendhi
    Over the past few decades, many of the phytochemicals have been shown to possess extraordinary anticancer effects, clinical tested, approved as drugs, and currently in use. A considerable number of phytochemicals either as a single-agent or combined with existing anticancer drugs at pre-clinical and clinical levels have been evaluated to date. However, the clinical trials on phytochemical evaluations against the world's top-ranked cancer, NSCLC, was found to be a very little. Some of the phytochemicals that showed significant anticancer activity against NSCLC in vitro and/or in vivo at the preclinical levels are highlighted in this review article. There are several impediments such as poor solubility, poor bioavailability, low stability, a requirement of high doses, safety and toxicity that limits the wide-spread use of phytochemicals in clinical oncology. Nanotherapeutic systems can help to overcome the aforementioned issues and wide open the gates to focus on phyto-oncotherapy, in particular NSCLC. The current review aims to summarize the importance of phytochemicals as anticancer agents, with a special mention on nano-formulations to treat non-small cell lung cancer (NSCLC).